Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > Original drug market: The prices of upstream raw materials remain high, and downstream small businesses are under great pressure to survive!

Original drug market: The prices of upstream raw materials remain high, and downstream small businesses are under great pressure to survive!

ECHEMI 2021-06-16

The pesticide market as a whole remained relatively stable last week, and most of the product prices and fluctuations were not too great; the demand for a few products in the foreign market has rebounded, and trading intentions have strengthened. At the same time, due to environmental protection issues, driving is not normal, market supply is tight, and prices Relatively strong or further upward adjustments, among which herbicides are relatively strong and the market demand is relatively good; a few insecticides and fungicides are also in a tight market. However, the overall performance was relatively weak and demand was weak.


herbicide


The overall performance of herbicides remained strong last week. The prices of most products were relatively firm, and upstream manufacturers maintained low inventories. The overall market supply was tight, and the prices of a few products continued to rise.


The quotation of glyphosate remained at about 48,000 yuan (in tons, the same below), and the supply remained tight. The quotation of glufosinate-ammonium manufacturers remained above 190,000 yuan, and the market supply was tight.


The prices of triazine raw materials, monoethylamine and cyanuric chloride, are stable: atrazine quotation is maintained at about 21,000 yuan, and the manufacturer drove normally, and the supply was relatively stable; the quotation of 97% simazine content remained at 24,000 yuan. The quotation of sulfonylurea is relatively stable. The market quotation of nicosulfuron remains at about 280,000 yuan, and the manufacturer's supply is stable; the quotation of quizalofop-p-ethyl remains at about 175,000 yuan, the supply is stable, the demand is weak, and the actual transaction can be Negotiation: The quotation of Bensulfuron-methyl is maintained at about 170,000 yuan, the manufacturer's supply is stable, and the actual transaction is negotiable. The quotation of trifluralin was maintained at around 46,000 yuan, with stable driving and relatively stable supply. The quotation of clethodim manufacturers remained at around 105,000 yuan, and the supply was relatively stable.


Quinclorac's manufacturers drove up again, the demand was weak, the price of more than 85% was maintained at about 150,000 yuan (100%), the demand was weak, and the supply was stable; the content of more than 95% was maintained at about 250,000. The supply of manufacturers is relatively stable, and the demand is weak; the downstream demand of mesotrione is weak. Last week, the quotation was maintained at about 150,000 yuan. The family supplied normally, and the actual transaction was negotiable; the market price of fluroxypyr maintained at 190,000 yuan Around this time, the factory drove normally, the supply was stable, and the actual transaction was low. The quotation for 96% of oxyfluorfen content was maintained at about 152,000 yuan, the demand was weak, and the supply was relatively stable; the quotation of fomesafen remained at about 90,000 yuan, the supply was relatively stable, and the demand was weak.


The market price of cyhalofop-butyl remained at around 172,000 yuan, and the market supply remained tight. The quotation for 96% of the market content of clodinafop-propargyl was raised to about 245,000 yuan, and the price was raised by 5,000 yuan. The market supply is tight and the driving rate is low. The market quotation of bispyrifen is maintained at around 360,000 yuan, the drive rate of manufacturers is low, and the supply is very tight. 2,4-D original drug manufacturers drove normally. Last week, the manufacturer's original drug price was raised to about 22,000 yuan, and the price was increased by 500 yuan. The demand is strong and the supply is tight. The quotation of the original drug of precachlor remained at around 36,500 yuan, and the manufacturer's supply was relatively tight.


Insecticide


The basic pattern of the pesticide market remains unchanged, and overall demand is weak. Market demand for a small number of products has started, and manufacturers have started to operate abnormally, and prices have continued to rise.


The downstream demand for pyrethroid products is general: the market quotation of lambda-cyhalothrin is maintained at about 185,000 yuan, and the manufacturers drive abnormally and the supply is tight; the market quotation of Bifenthrin is increased to about 235,000 yuan, and the price is increased by 5,000 yuan. , The market supply is tight.


The price of nicotine imidacloprid was raised to about 140,000 yuan, and the price was increased by 5,000 yuan. The supply of manufacturers was tight, and the sales of channel merchants were low; the market demand for acetamiprid original medicine was weak, and the market price was raised to about 118,000 yuan, and the price was increased by 3,000 yuan. The supply is tight, and the operating rate of manufacturers is low. The market price of thiamethoxam remained at around 88,000 yuan. The market supply was stable, the demand started, and the actual transaction was low. Nitenpyram is reported to be maintained at around 145,000 yuan, with weak demand and stable supply. The quotation of pymetrozine was lowered to about 165,000 yuan last week, the market supply was stable, and the actual transaction volume of channel vendors was low.


The quotation of phoxim is maintained at about 38,000 yuan (100% off), and the supply is tight, and manufacturers do not take orders; the market quotation of profenofos contains 90% of 63,000 yuan, and the content of 94% or more is maintained at more than 65,000 yuan. The driving rate is low, and the market supply is stable; the driving rate of malathion technical is still low, and the price is relatively stable. The 90% content is maintained at 28,000 yuan, and the 95% content is maintained at about 29,000 yuan. Manufacturers can take orders , Normal delivery.


The quotation of the killing bill is maintained at about 105,000 yuan, the actual transaction is negotiable, the quotation of 95% of the pesticide content is maintained at about 36,000, the quotation of 90% content is maintained at about 34,000, the actual transaction is negotiable, and the market source of goods stable. The quotation of fipronil is maintained at around RMB 550,000, the market supply is stable, and the manufacturer supplies normally, and the actual transaction is negotiable. The market price of Chlorfenapyr is maintained at around 250,000 yuan, the supply is stable, and the actual transaction is negotiable. The quotation of Avitamin powder remained at around 670,000 yuan last week, and the supply remained stable; the quotation of emamectin benzoate remained at around 950,000 yuan last week, and the market supply was stable.


Fungicide


The overall market for fungicides remained relatively weak, most of the products were generally traded, and the prices remained relatively stable.


The quotation of triazole difenoconazole was maintained at about 180,000 yuan, the market supply was stable, and the actual transaction was negotiable; the quotation of propiconazole was raised to about 130,000 yuan, and the price of 2,000 yuan was increased, the market supply was tight; the ciproconazole quotation Maintained at about 305,000 yuan, the manufacturer has a certain amount of inventory, the market supply is normal, and the actual transaction is negotiable; the price of triadimefon content above 95% is maintained at about 72,000 yuan, the supply is relatively stable, and the actual transaction is negotiable; 3. The price of ciprodazole was maintained at around 63,000 yuan, the supply was stable, and the demand was tight; the hexaconazole quotation remained at around 128,000, and the supply was relatively stable. The quotation of tebuconazole original drug remained at around 78,000 yuan, with stable supply, low actual transactions and weak demand. The mainstream market price of 95% paclobutrazol is maintained at around 85,000 yuan, the actual transaction is negotiable, and the supply is stable; the content of 90% is maintained at about 80,000 yuan (100%), and the supply is relatively stable. The supply of epoxiconazole in the market has improved, and the manufacturer's quotation is maintained at about 39 yuan, the demand is weak, and the actual transaction is negotiable. Flusilazole is maintained at about 400,000 yuan, the driving rate is low, and the supply is tight.


The quotation of iprodione was raised to about 200,000 yuan, the supply of goods was relatively tight, and the actual transaction was high. The price of hymexazol was maintained at more than 115,000 yuan, and the supply was stable. The market price of prochloraz manufacturers with a content of 97% remained at around 68,000 yuan. The supply was stable, the demand was weak, and the actual transaction was negotiable. The price of metalaxyl original drug is maintained at around 90,000 yuan, and the supply is relatively stable. The quotation of pyraclostrobin is maintained at about 155,000 yuan, the supply is stable, the demand is weak, and the actual effect is negotiable; the price of azoxystrobin content of 98% is maintained at about 220,000 yuan, the manufacturer's drive rate is low, and the supply is tight. The quotation of Fumei Shuang remained at around 18,000 yuan, and the supply was relatively tight. The quotation of dimethomorph is maintained at around 100,000 yuan, and the supply is stable. The price of fludioxonil is maintained at around 810,000 yuan, the supply is stable, and the actual transaction is negotiable. The quotation of boscalid was maintained at around 340,000 yuan, and the supply was tight. The current price of picoxystrobin is relatively stable, and the manufacturer's price is about 460,000 yuan. The supply is tight and the fluctuation is not large.


Intermediate


Last week, the overall market for intermediates started stable, the prices of most products remained relatively stable, and the tightness of supply from manufacturers improved. The quotation price of the cyfluthrin factory was maintained at about 200,000 yuan, and the supply of manufacturers remained tight; the price of ether aldehyde remained at about 95,000 yuan, the market supply was stable, and the export quotation of cyanuric chloride manufacturers remained at 15,000 yuan. The supply is relatively stable. Spermine manufacturers have a large amount of wastewater and a low operating rate. The price is maintained at more than 27,000 yuan, and the market supply is tight. The quotation of ethyl chloride manufacturers is maintained at about 20,000 yuan, the operating rate is low, and the supply is tight. The quotation of imidazolidine was maintained at around 38,000 yuan, and the supply was tight. The price of 2-chloro-5chloromethylthiazole was maintained at around 52,000 yuan, and the market supply was stable; the oxadiazine manufacturers did not drive normally, and the price remained at around 35,000 yuan, and the supply was stable. The quotation of cyanoethyl ester is maintained at around 50,000 yuan, and the supply is relatively stable. CCMP's quotation is maintained at around 90,000 yuan, and the supply is relatively stable. The price of amine ether remained above 37,000 yuan, the driving rate was low, and the supply was relatively tight. The current price of the downstream triazoles of triazole is relatively stable, the content of more than 99% is maintained at about 28,000 yuan, and the price of the content of 95% is maintained at about 26,000 yuan, and the supply is relatively stable. The price of glyphosate remained at around 18,000 yuan, and the supply was tight. The price of the basic raw material dimethyl sulfoxide was maintained at around 13,000 yuan this week, and the supply was stable; the price of solvent oil was relatively stable. The current price is 10,000 yuan and the supply is normal.


Late prediction


Last week, the domestic market maintained the trend of last week. The overall market remained relatively weak. Some products have passed the season. A small number of products have entered the replenishment stage. Trading intentions are weak. Most products have stable prices. Some products in foreign markets need to be in good condition. , Trading intentions have strengthened, resulting in tight supply of some products in the market. At the same time, the price of upstream raw materials remains high, and the cost of downstream production and synthesis enterprises has always been high. Some small production enterprises are under pressure to survive and choose to stop and wait. The market is expected to be stable in the short term.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.